Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HURN | EXK |
|---|---|---|
| Price | $160.10 | $8.60 |
| Change today | ▼ 1.26% | ▲ 0.00% |
| Market cap | $2.55B | $2.55B |
| Return, 3 months | +51.1% | +7.2% |
| Return, year to date | -7.4% | -8.5% |
| Return, 1 year | +6.6% | +10.0% |
| P/E (TTM) | 24.1 | 43.0 |
| P/B | 6.6 | 3.6 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +114.8% |
| Net profit growth (YoY) | – | -278.1% |
| Gross margin | – | 17.6% |
| Operating margin | – | 8.2% |
| Net margin | – | -25.5% |
| Return on equity | – | -22.4% |
| Analyst target vs. price | +16.5% | +75.8% |
| Analyst buy share | 100% | 80% |
| RSI (14) | 55 | 37 |
| 30-day volatility | 35.3% | 63.9% |
| Max drawdown, 1 year | -51.4% | -47.5% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
